Two CpG sites were hypermethylated in CD4+ and CD8+ T cells from MS patients compared to controls; one CpG upstream of the TMEM48 gene and another CpG in the last exon of the APC2 gene [40]. Here, CD8A is linked to myeloid sarcoma.